IVF Industry Trade Group Uses Advocacy Non-Profit to Push Money-Making Agenda
By Editor,
ReproTech Truths
| 04. 10. 2019
In the last few years, ASRM has aggressively courted RESOLVE, once a purely grassroots group of women helping women get support for infertility. RESOLVE’s grassroots nationwide membership was its crown jewel.
Eager to gain access to RESOLVE’s membership, Big Pharma, along with ASRM, have each made large cash infusions in the form of sponsorships and events.

Industry Mouth Piece
RESOLVE has since become a lobbying group for the industry. Its well-compensated executive team gets paid by Coulter Companies, now MCI USA according to RESOLVE’s latest tax filings. The industry-funded team works alongside its corporate council, donors and advocates — a who’s who of IVF clinic owners and service providers — to mobilize consumers to do its bidding: lobby to get insurance companies to compensate the industry for dispensing IVF cycles. It opens up a large untapped revenue stream.
RESOLVE today announced its full embrace of ASRM with an email blast that reads in part:
“ASRM has committed to a three-year investment in RESOLVE’s Access to Care programs, which will allow for new staff resources to grow these important programs...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Lizzy Lawrence, Stat News | 10.14.2025